| Product Name | MF | CAS | Details |
|---|
| CBR1-IN-4 | C17H13ClN2O3 | 1798284-64-6 | Details |
| CBR1-IN-3 | C16H11ClN2O3 | 891101-69-2 | Details |
| CBR1-IN-7 | C22H22O13 | 1119826-35-5 | Details |
| CHI3L1-IN-1 | C22H27Cl2N3O | 2982256-78-8 | Details |
| CEP-28122 mesylate hydrochloride | C29H40Cl2N6O6S | 1354545-57-5 | Details |
| CBR1-IN-5 | C17H13ClN2O3 | 1798284-62-4 | Details |
| ChEs/MAOs-IN-2 | C15H12N2O3S | 693268-77-8 | Details |
| CHI3L1-IN-2 | C26H37ClN4 | 2982257-63-4 | Details |
| C3TD879 | C22H28N4O | 2850259-33-3 | Details |
| CDK8-IN-14 | C18H13N3O2 | 2924193-12-2 | Details |
| CCR8 antagonist 3 | C29H33N3O4 | 912463-57-1 | Details |
| c-Myc inhibitor 14 | C38H52BN3O7 | 2581994-88-7 | Details |
| CD 10899 | C34H50N8O4 | 1331770-20-7 | Details |
| CDK2-IN-23 | C20H27F3N6O3S | 2488073-20-5 | Details |
| CSF1R-IN-21 | C24H20F3N5O3 | 2935479-62-0 | Details |
| CYP19A1/CYP11B2-IN-1 | C12H11N3O | 183500-36-9 | Details |
| CSF1R-IN-20 | C25H26F3N5O3 | 2935479-57-3 | Details |
| CSF1R-IN-23 | C27H37N3O2 | 2935480-17-2 | Details |
| CYP4A11/CYP4F2-IN-2 | 2280834-99-1 | Details |
| Calcium mesoxalate | C6H6CaO12 | 21085-60-9 | Details |
| CXF-009 | C33H38N8O5 | 2727084-00-4 | Details |
| DDABT1 | C40H34N4O4 | 2777045-35-7 | Details |
| COX-2-IN-40 | C19H11ClO3 | 444790-64-1 | Details |
| CZL80 | C19H14N2O4S | 313482-91-6 | Details |
| COX-2-IN-39 | C17H17N3O3S2 | 1018480-89-1 | Details |
| BChE-IN-25 | C17H23NO2 | 79183-25-8 | Details |
| BIO-7488 | C23H25N7O3 | 2573211-25-1 | Details |
| CXF-007 | C34H33N7O5 | 2727083-99-8 | Details |
| COX-2-IN-43 | C18H11Cl2F3N2O3 | 1023524-40-4 | Details |
| DB18 | C24H18ClN7O3 | 2587177-94-2 | Details |
| CTSL/CAPN1-IN-2 | C34H40N4O6 | 2410075-64-6 | Details |
| BRD4 Inhibitor-30 | C28H38N6O4 | 1789731-20-9 | Details |
| CB7993113 | C15H10BrNO5 | 819827-50-4 | Details |
| Anti-osteoporosis agent-3 | 2944463-16-3 | Details |
| Atrazine-3-mercaptopropanoic acid | C11H19N5O2S | 125454-31-1 | Details |
| CVN766 | C20H21F3N8O | 1803557-42-7 | Details |
| BAY-155 | C28H28F3N7OS | 2163769-52-4 | Details |
| BChE-IN-23 | C20H19FN2O | 2020357-32-6 | Details |
| DCLK1-IN-5 | C26H32ClN7O3S2 | 3028774-14-0 | Details |
| Aurora kinase inhibitor-11 | C11H10BrN3OS | 923946-98-9 | Details |
| BET-IN-20 | 1300735-76-5 | Details |
| Casein kinase 1δ-IN-15 | C19H17FN6O | 2765264-27-3 | Details |
| CDK2-IN-18 | 364735-73-9 | Details |
| BTK-IN-30 | C23H21F2N5O3 | 2662512-15-2 | Details |
| cGAS-IN-2 | C16H18Cl2N2O2 | 2765273-11-6 | Details |
| CVN293 | C14H10FN7O | 2815296-08-1 | Details |
| COX-1/2-IN-6 | 327024-84-0 | Details |
| BAY-6096 | C21H23N6O2.Cl | 2313483-41-7 | Details |
| AQP3-IN-1 | C11H9AuCl2N2 | 198711-19-2 | Details |
| AR antagonist 5 | C23H21F3N6O2 | 2902679-53-0 | Details |
| BRD4 Inhibitor-29 | C21H28N2O3 | 902563-50-2 | Details |
| TM38837 | C27H20Cl2F3N7O | 1034264-77-1 | Details |
| BAY-5516 | C23H17ClF4N2O3 | 2891706-79-7 | Details |
| Antifungal agent 87 | C14H14O4 | 692730-21-5 | Details |
| Anti-infective agent 9 | C14H11F3N4S2 | 758689-17-7 | Details |
| CARM1-IN-4 | C24H42N2O4 | 2878481-07-1 | Details |
| CDK2-IN-27 | C18H21N7O2 | 2927473-94-5 | Details |
| Antitumor agent-138 | C20H21N3O4 | 2975168-22-8 | Details |
| BET-IN-23 | C29H34FN3O5 | 2953287-57-3 | Details |
| ATAD2-IN-1 | C22H26N6O5 | 3004556-06-0 | Details |
| ATF4-IN-1 | C24H21Cl2N3O4 | 2991057-76-0 | Details |
| COX-1-IN-1 | C20H21NO3 | 1369503-03-6 | Details |
| Divarasib adipate | 2762240-36-6 | Details |
| eeAChE/eqBuChE-IN-1 | C14H16N2O2 | 2921654-26-2 | Details |
| Antibacterial agent 172 | C21H21N9O5S2 | 3023114-93-1 | Details |
| Antifungal agent 100 | C23H21N3O4S | 2975157-18-5 | Details |
| DHX9-IN-5 | C23H24ClN5O4S | 2973398-17-1 | Details |
| EBOV-IN-3 | C21H28N2O4S2 | 2896193-40-9 | Details |
| EBOV-IN-8 | C19H24N2O3S2.C4H4O4 | 286854-12-4 | Details |
| Antiproliferative agent-22 | C17H13N3O3 | 1374305-45-9 | Details |
| Antitumor agent-100 | C17H14ClN3O | 2841750-32-9 | Details |
| DNMT-IN-3 | C37H39N7O | 1683516-27-9 | Details |
| Antitumor agent-122 | 2378641-43-9 | Details |
| ATF4-IN-2 | C24H21BrClN5O4 | 2991057-60-2 | Details |
| DHODH-IN-24 | C26H26N4 | 418775-30-1 | Details |
| DPP1-IN-1 hydrate | C23H23FN4O4.H2O | 2971064-13-6 | Details |
| CVM-05-002 | C16H14N4O3S2 | 2428738-43-4 | Details |
| Antidiabetic agent 5 | C17H15N3O4S | 2152667-21-3 | Details |
| Antitumor agent-144 | C25H26N4O4 | 137346-42-0 | Details |
| ASN02563583 | C25H24N4O3S | 483283-39-2 | Details |
| CSF1R-IN-22 | C20H20N6O3 | 2760585-35-9 | Details |
| AS115 | C21H32FNO4 | 926657-43-4 | Details |
| CRT0066101 | C18H22N6O | 956123-34-5 | Details |
| DNMT/HDAC-IN-1 | 2095619-17-1 | Details |
| AR/AR-V7-IN-1 | C36H43ClFN7O2 | 2964558-54-9 | Details |
| DHODH-IN-25 | C22H19ClF5N3O5 | 2619531-95-0 | Details |
| DNA-PK-IN-12 | C21H24N8O2 | 2792146-91-7 | Details |
| Anticancer agent 129 | C18H17N3 | 135882-37-0 | Details |
| Arfolitixorin sulfate | C20H25N7O10S | 149930-93-8 | Details |
| DS43260857 | C19H16F3N3O3S | 1612158-07-2 | Details |
| BTL-MK | C24H24O6 | 2758569-43-4 | Details |
| Anticancer agent 183 | 3018960-58-9 | Details |
| EBOV-IN-7 | C18H19ClN4O3S | 68207-16-9 | Details |
| Dopamine D4 receptor ligand 2 | C20H24ClN3O2 | 219125-63-0 | Details |
| CTPS1-IN-2 | C24H27N7O5S | 2377000-84-3 | Details |
| AQIM-I | C17H13N2O2.I | 2247881-73-6 | Details |
| Arginase inhibitor 7 | C14H29BN6O5 | 2377392-07-7 | Details |
| BaENR-IN-1 | C12H8ClNO4 | 1071966-17-0 | Details |
| DPP-4-IN-9 | C28H23N5O4 | 2906243-39-6 | Details |
| DU-14 | C22H38N2O4S | 186303-55-9 | Details |
| Product Total： Product Page： | ||||
| 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 | ||||